American Transplant Congress June 12, 2016
American Transplant Congress June 12, 2016 Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in de novo living donor kidney transplant recipients. » Download Full Abstract
American Transplant Congress June 12, 2016 Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in de novo living donor kidney transplant recipients. » Download Full Abstract
International Society for Cellular Therapy, Miltenyi Biotec Corporate Symposium, May 27, 2015, Las Vegas, NV Ann LeFever, PhD to present “Large Scale GMP Manufacturing of Regulatory T Cells for Tolerance Induction”
“A kidney transplant that lasts for life. It’s the ultimate goal. But the drugs that keep a donor organ going also pose the greatest threat. Now a new approach to fighting off rejection. Chicago based TRACT Therapeutics aims to remove the need for organ transplant patients to take immunosuppressive drugs by Continue reading